Genascence
Developing revolutionized life changing gene therapies for prevalent musculoskeletal and joint diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD57—86m (Dealroom.co estimates May 2022.)
Palo Alto California (HQ)
Authorizing premium user...